IQVIA Holdings Inc. (NYSE:IQV) Shares Purchased by Earnest Partners LLC

Earnest Partners LLC grew its position in IQVIA Holdings Inc. (NYSE:IQV - Free Report) by 19.3% in the 4th quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 426,399 shares of the medical research company's stock after purchasing an additional 68,870 shares during the period. Earnest Partners LLC owned about 0.23% of IQVIA worth $83,792,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in IQV. Criteria Caixa S.A.U. bought a new position in shares of IQVIA in the fourth quarter valued at approximately $51,217,000. Coldstream Capital Management Inc. raised its stake in shares of IQVIA by 5.1% during the fourth quarter. Coldstream Capital Management Inc. now owns 3,656 shares of the medical research company's stock valued at $718,000 after acquiring an additional 179 shares during the last quarter. Integrated Wealth Concepts LLC raised its stake in shares of IQVIA by 25.8% during the fourth quarter. Integrated Wealth Concepts LLC now owns 2,761 shares of the medical research company's stock valued at $543,000 after acquiring an additional 566 shares during the last quarter. Adage Capital Partners GP L.L.C. raised its stake in IQVIA by 63.7% in the fourth quarter. Adage Capital Partners GP L.L.C. now owns 38,860 shares of the medical research company's stock worth $7,636,000 after buying an additional 15,127 shares in the last quarter. Finally, Syon Capital LLC raised its stake in IQVIA by 34.0% in the fourth quarter. Syon Capital LLC now owns 1,138 shares of the medical research company's stock worth $224,000 after buying an additional 289 shares in the last quarter. Hedge funds and other institutional investors own 89.62% of the company's stock.

IQVIA Price Performance

Shares of NYSE:IQV traded up $1.65 during midday trading on Wednesday, reaching $155.10. 2,232,397 shares of the company's stock traded hands, compared to its average volume of 1,431,923. IQVIA Holdings Inc. has a 1 year low of $135.97 and a 1 year high of $252.88. The company has a market cap of $27.35 billion, a P/E ratio of 20.68, a PEG ratio of 1.99 and a beta of 1.46. The company has a debt-to-equity ratio of 2.12, a quick ratio of 0.84 and a current ratio of 0.84. The company has a fifty day simple moving average of $169.86 and a two-hundred day simple moving average of $192.72.

IQVIA (NYSE:IQV - Get Free Report) last issued its earnings results on Thursday, February 6th. The medical research company reported $2.90 EPS for the quarter, missing analysts' consensus estimates of $3.11 by ($0.21). IQVIA had a net margin of 8.91% and a return on equity of 28.81%. Equities analysts predict that IQVIA Holdings Inc. will post 10.84 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

IQV has been the topic of a number of recent analyst reports. Robert W. Baird cut their price target on shares of IQVIA from $212.00 to $210.00 and set a "neutral" rating on the stock in a report on Tuesday, January 21st. Citigroup reduced their price target on IQVIA from $225.00 to $210.00 and set a "neutral" rating for the company in a research report on Tuesday, March 4th. Truist Financial dropped their price objective on IQVIA from $263.00 to $216.00 and set a "buy" rating for the company in a research note on Thursday, April 10th. StockNews.com lowered IQVIA from a "buy" rating to a "hold" rating in a research note on Wednesday, March 12th. Finally, Stifel Nicolaus decreased their price objective on IQVIA from $273.00 to $261.00 and set a "buy" rating on the stock in a research report on Friday, February 7th. Eight equities research analysts have rated the stock with a hold rating, sixteen have given a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus price target of $237.62.

IQVIA Company Profile

IQVIA Holdings Inc engages in the provision of advanced analytics, technology solutions, and clinical research services to the life sciences industry in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions.